306 related articles for article (PubMed ID: 15857393)
1. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
Wang C; Buck DC; Yang R; Macey TA; Neve KA
J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393
[TBL] [Abstract][Full Text] [Related]
2. D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent.
Beazely MA; Tong A; Wei WL; Van Tol H; Sidhu B; MacDonald JF
J Neurochem; 2006 Sep; 98(5):1657-63. PubMed ID: 16879713
[TBL] [Abstract][Full Text] [Related]
3. Stimulation by vasopressin of ERK phosphorylation and vector-driven water flux in astrocytes is transactivation-dependent.
Du T; Song D; Li H; Li B; Cai L; Hertz L; Peng L
Eur J Pharmacol; 2008 Jun; 587(1-3):73-7. PubMed ID: 18486126
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor treatment switches δ-opioid receptor-stimulated extracellular signal-regulated kinases 1 and 2 signaling from an epidermal growth factor to an insulin-like growth factor-1 receptor-dependent mechanism.
Eisinger DA; Ammer H
Mol Pharmacol; 2011 Feb; 79(2):326-35. PubMed ID: 21078885
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells.
Pellegrino MJ; Stork PJ
J Neurochem; 2006 Dec; 99(6):1480-93. PubMed ID: 17223854
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation.
Clark MA; Gonzalez N
Regul Pept; 2007 Dec; 144(1-3):115-22. PubMed ID: 17688958
[TBL] [Abstract][Full Text] [Related]
7. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
8. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes.
Clerk A; Aggeli IK; Stathopoulou K; Sugden PH
Cell Signal; 2006 Feb; 18(2):225-35. PubMed ID: 15936927
[TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
Ichiki T; Tokunou T; Fukuyama K; Iino N; Masuda S; Takeshita A
Biochem Biophys Res Commun; 2004 Oct; 323(2):402-8. PubMed ID: 15369766
[TBL] [Abstract][Full Text] [Related]
10. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2).
Iwakura Y; Wang R; Abe Y; Piao YS; Shishido Y; Higashiyama S; Takei N; Nawa H
J Neurochem; 2011 Jul; 118(1):57-68. PubMed ID: 21534959
[TBL] [Abstract][Full Text] [Related]
12. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation.
Yano S; Macleod RJ; Chattopadhyay N; Tfelt-Hansen J; Kifor O; Butters RR; Brown EM
Bone; 2004 Sep; 35(3):664-72. PubMed ID: 15336602
[TBL] [Abstract][Full Text] [Related]
14. Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation.
Yang M; Zhang H; Voyno-Yasenetskaya T; Ye RD
Mol Pharmacol; 2003 Aug; 64(2):447-55. PubMed ID: 12869650
[TBL] [Abstract][Full Text] [Related]
15. ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors.
Du T; Li B; Liu S; Zang P; Prevot V; Hertz L; Peng L
Neurochem Int; 2009 Dec; 55(7):593-600. PubMed ID: 19501623
[TBL] [Abstract][Full Text] [Related]
16. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
[TBL] [Abstract][Full Text] [Related]
17. PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy.
Fan CY; Katsuyama M; Yabe-Nishimura C
Biochem J; 2005 Sep; 390(Pt 3):761-7. PubMed ID: 15913451
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons.
Fiorentini C; Mattanza C; Collo G; Savoia P; Spano P; Missale C
J Neurochem; 2011 Apr; 117(2):253-63. PubMed ID: 21272002
[TBL] [Abstract][Full Text] [Related]
19. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
20. Effect of urotensin II on PC12 rat pheochromocytoma cells.
Aita Y; Kasahara T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2010 Feb; 22(2):83-91. PubMed ID: 20025629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
